Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 3 1

Status

Unknown 5 Completed 5 Recruiting 4 Terminated 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Hemorrhage 1

Interventions

Carboplatin 108 Cisplatin 98 Paclitaxel 79 pembrolizumab 70 Gemcitabine 60 Pemetrexed 49 Cyclophosphamide 48 Dexamethasone 47 Docetaxel 46 durvalumab 44 Capecitabine 44 Radiotherapy 42 Doxorubicin 40 Lenalidomide 38 Specimen Handling 37 Nivolumab 37 Oxaliplatin 35 Rituximab 34 Magnetic Resonance Spectroscopy 33 Fluorouracil 33 Etoposide 32 Bevacizumab 32 Vincristine 30 atezolizumab 29 Radiation 28 Leucovorin 28 Bortezomib 26 Prednisone 23 Letrozole 23 Fulvestrant 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Active not recruiting × Tranexamic Acid × Clear all

NCT02261415 2022-10-26

HeLiX

Sunnybrook Health Sciences Centre

Phase 3 Active not recruiting

Hemorrhage, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡